About Viomics
Viomics is a Healthcare company based in Phoenix (United States) founded in 2011, and was acquired by Exact Sciences in March 2020. Provider of liquid biopsy tests for the detection of lung cancer. The company was acqui-hired. Viomics offers products and services including SEO Services, PPC Advertising, Social Media Marketing, Web Design, and Content Marketing. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Liquid Biopsy. Its competitors include Guardant Health, GRAIL and Delfi Diagnostics; 3 of its 3 listed competitors have raised funding.
Company details
Viomics was founded in 2011 and is headquartered in Phoenix, United States. Operations focus on the biotechnology sector, where liquid biopsy tests are developed for non-small cell lung cancer (NSCLC) detection. The LungVantage platform is utilized to measure three blood markers for early-stage identification. Additionally, the ActiveTargeting assay is employed for real-time monitoring of tumor events through biomarkers such as ALK.
- Headquarters Phoenix, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website viomics.com
- Social LinkedIn Facebook Instagram YouTube
- Acquired by Exact Sciences (Mar 2020)
- Investors
- Acquired byExact Sciences
(Mar 2020)
Products & Services of Viomics
Viomics offers a comprehensive portfolio of products and services, including SEO Services, PPC Advertising, Social Media Marketing, Web Design, and Content Marketing.
Improves website rankings and organic traffic for businesses.
Manages targeted ads to drive immediate leads and sales.
Enhances brand presence and interaction on social platforms.
Creates user-friendly websites to convert visitors into customers.
Develops valuable content to attract and engage target audiences.
Apps and channels of Viomics
its YouTube channel Comrade Digital Marketing Agency has 223 subscribers and 30 videos.
Videos from Viomics
The most watched videos on Viomics's YouTube channel, Comrade Digital Marketing Agency (223 subscribers). Click a video to play it here.
More on Comrade Digital Marketing Agency.
Investors in Viomics
Viomics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Exact Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Non-invasive molecular diagnostic tests for cancer detection are provided. | 1995 | exactsciences.com | Madison, United States |
Investor details for Viomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Viomics
2 dated milestones of Viomics across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Viomics is founded.
- Exit Acquired by Exact Sciences.
Competitors of Viomics
Viomics has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, GRAIL and Delfi Diagnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| delfidiagnostics.com | 2019 | Baltimore, United States | $331.59M | Provider of DNA sequencing for cancer detection |
Detailed competitors of Viomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Viomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Viomics
Complete news archive for Viomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viomics
Viomics was founded in 2011.
Viomics is headquartered in Phoenix, United States. It is registered at Phoenix, Arizona, United States.
Viomics was founded in 2011 and is headquartered in Phoenix, United States. Operations focus on the biotechnology sector, where liquid biopsy tests are developed for non-small cell lung cancer (NSCLC) detection. The LungVantage platform is utilized to measure three blood markers for early-stage identification. Additionally, the ActiveTargeting assay is employed for real-time monitoring of tumor events through biomarkers such as ALK.
Viomics's top competitors include Guardant Health, GRAIL and Delfi Diagnostics.
Viomics offers SEO Services, PPC Advertising, Social Media Marketing, Web Design, and Content Marketing.
Viomics has 1 investor. Key investors include Exact Sciences.
Yes. Viomics was acquired by Exact Sciences in March 2020.